Other topic
Ozempic in Morocco: an innovative drug, but reserved for the wealthiest
After the controversy over its misuse, Ozempic is now at the center of a new debate: access to generics. In Morocco, a five-year exclusivity clause could delay affordable alternatives, effectively turning the treatment into a "medicine for the wealthy."
Article réservé aux abonnés
Continuez la lecture en vous abonnant
Accédez à l'intégralité des articles, analyses et enquêtes de Médias24 sans limitation.
